Skip to main content
. 2018 Apr 17;9(29):20426–20438. doi: 10.18632/oncotarget.24921

Table 2. Nucleotide and amino acid changes generated from the colon cancer mutation array test.

Types Gene Nucleotide change Amino acid change Genotype
CD166 positive CRC
Carcinoma FBXW7 c.1393C>T p.R465C Mutant
Carcinoma TP53 c.527G>T p.C176F Mutant
Carcinoma KRAS c.436G>A p.A146T Mutant
CD166 negative CRC
Carcinoma TP53 c.527G>A p.C176Y Mutant
CD166 positive CAD
Adenoma APC c.4081_4082delCC p.P1361fs*13 Mutant
Adenoma APC c.4391_4394delAGAG p.E1464fs*8 Mutant
Adenoma APC c.4118_4118delC p.P1373fs*42 Mutant
Adenoma APC c.4216C>T p.Q1406* Mutant
Adenoma APC c.3916G>T p.E1306* Mutant
Adenoma APC c.3956delC p.P1319fs*2 Mutant
Adenoma KRAS c.436G>A p.A146T Mutant
Adenoma KRAS c.35G>A p.G12D Mutant
Adenoma KRAS c.34G>A p.G12S Mutant
Adenoma SRC c.1591C>T p.Q531* Mutant
Adenoma TP53 c.473G>A p.R158H Mutant
Adenoma PIK3CA c.1633G>A p.E545K Mutant
CD166 negative CAD
Adenoma APC c.4081_4082delCC p.P1361fs*13 Mutant